Gene · 85340
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Electrospray triple quadrupole mass spectrometry guides pathologists to suggest appropriate molecular testing in the identification of rare hemoglobin variants. | J Mass Spectrom Adv Clin Lab | 2024 | 38371348 | PubTator, text mining | PubMed |
| MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC. | Clin Chem Lab Med | 2024 | 38353144 | PubTator, text mining | PubMed |
| Comparing Hearing Loss in Children with Adults Living with Sickle Cell Disease and Sickle Cell Traits. | Niger J Clin Pract | 2024 | 38317038 | PubTator, text mining | PubMed |
| Hb Hebei [α20 (B1) His→Leu; HBA2:C.62A > T]: A Novel Hemoglobin Variant Found during Measurement of Glycated Hemoglobin. | Hemoglobin | 2024 | 38314585 | PubTator, text mining | PubMed |
| Telecoaching as a new training method for elderly people: a systematic review. | Aging Clin Exp Res | 2024 | 38305822 | PubTator, text mining | PubMed |
| The effectiveness of expanded carrier screening based on next-generation sequencing for severe monogenic genetic diseases. | Hum Genomics | 2024 | 38297315 | PubTator, text mining | PubMed |
| Third-generation sequencing identified two rare α-chain variants leading to hemoglobin variants in Chinese population. | Mol Genet Genomic Med | 2024 | 38284449 | PubTator, text mining | PubMed |
| Development of preimplantation genetic testing for monogenic reference materials using next-generation sequencing. | BMC Med Genomics | 2024 | 38262988 | PubTator, text mining | PubMed |
| Comprehensive and accurate genome analysis at scale using DRAGEN accelerated algorithms. | bioRxiv | 2024 | 38260545 | PubTator, text mining | PubMed |
| High-Oxygen-Affinity Hemoglobins-Case Series and Review of the Literature. | J Clin Med | 2024 | 38256595 | PubTator, text mining | PubMed |
| Differences in aqueous humor protein profiles in patients with proliferative diabetic retinopathy before and after aflibercept treatment. | BMC Ophthalmol | 2024 | 38254055 | PubTator, text mining | PubMed |
| GC-MS analysis, molecular docking, and pharmacokinetic studies of Multidentia crassa extracts' compounds for analgesic and anti-inflammatory activities in dentistry. | Sci Rep | 2024 | 38253619 | PubTator, text mining | PubMed |
| Biophysical chemistry behind sickle cell anemia and the mechanism of voxelotor action. | Sci Rep | 2024 | 38253605 | PubTator, text mining | PubMed |
| Computational fragment-based drug design of potential Glo-I inhibitors. | J Enzyme Inhib Med Chem | 2024 | 38247330 | PubTator, text mining | PubMed |
| Chronic disease prevalence in a population with structural hemoglobin disorders undergoing diabetes diagnosis: A bayesian approach. | Heliyon | 2024 | 38223742 | PubTator, text mining | PubMed |
| Characterizing the pathogenicity of genetic variants: the consequences of context. | NPJ Genom Med | 2024 | 38195641 | PubTator, text mining | PubMed |
| Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy. | Mol Cancer | 2024 | 38195537 | PubTator, text mining | PubMed |
| Transcriptional signals of transformation in human cancer. | Genome Med | 2024 | 38195504 | PubTator, text mining | PubMed |
| Erratum to: Comparing the two leading erythroid lines BEL-A and HUDEP-2. | Haematologica | 2024 | 38186343 | PubTator, text mining | PubMed |
| Preliminary anticancer evaluation of new Pd(II) complexes bearing NNO donor ligands. | Saudi Pharm J | 2024 | 38178853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/85340/papers?page=11